Seven days. That’s how long until the two most-watched investment banks in the world tell you how Q2 went. Goldman Sachs reports Monday, July 14. Morgan Stanley follows Tuesday, July 15. Banks open earnings season every quarter, and these two always get disproportionate attention — not because they’re the biggest, but because the market treats them as proxies for something larger: whether the M&A cycle is real, whether trading desks are still generating, whether the capital markets business can sustain what’s been an extraordinary run.
What most people aren’t doing is separating the stories. Goldman and Morgan Stanley are often lumped together as bulge-bracket investment banks. That’s technically accurate and strategically misleading. These two firms have made fundamentally different bets about what investment banking looks like in the next decade. Q2 earnings will reveal which bet is paying off right now — and which company offers a more durable opportunity for traders who aren’t just playing the next two weeks.
Q1 Already Set a High Bar
Goldman reported Q1 2026 net revenues of $17.23 billion, net earnings of $5.63 billion, and diluted EPS of $17.55 — compared to $14.12 in Q1 2025, a 24% increase year-over-year. Return on average equity came in at 19.8%, with annualized return on tangible common equity at 21.3%. That’s a strong quarter by any measure, driven primarily by higher revenues in Global Banking and Markets. Q1 deal flow was exceptional across the industry. Global M&A hit approximately $1.2 trillion in Q1 — a 42% increase over Q1 2025 — and Goldman was in the middle of it.
Morgan Stanley reported Q1 2026 net revenues of $20.6 billion and EPS of $3.43, with a ROTCE of 27.1%. Morgan Stanley’s revenue base is actually larger than Goldman’s this quarter because of its Wealth Management division — a recurring fee engine that Goldman still doesn’t have at the same scale. Net new wealth assets came in at $118 billion in Q1, with fee-based asset flows of $54 billion. That’s not a trading business. That’s a compounding machine.
For Q2, Goldman’s revenue forecast sits around $15.88 billion. The Q2 EPS estimate from consensus stands near $13.75 to $14.01 — a meaningful step down from Q1’s $17.55, reflecting that Q1 benefited from both the M&A surge and unusual market volatility that generates trading revenue. Morgan Stanley’s Q2 report arrives July 15. The financial sector broadly is projecting EPS growth of approximately 12.5% and revenue growth of 8.1% year-over-year for Q2.
The Strategy Divergence Is the Real Story
Here’s where it gets interesting. Goldman Sachs has deliberately stayed concentrated in investment banking, trading, and alternative asset management. It is the premier franchise for those businesses globally. When markets are volatile and deal flow is strong, Goldman prints extraordinary numbers. The Q1 ROE of 19.8% is the proof. The risk is that Goldman’s revenue is feast-or-famine. A quiet M&A market or a risk-off trading environment compresses earnings rapidly.
Morgan Stanley made a different bet. Over the past decade, the firm has systematically shifted its mix toward wealth management and investment management — building a high-margin, recurring fee engine that doesn’t depend on a strong M&A quarter to generate returns. Wealth Management now contributes a substantial portion of total revenue, and those assets — once onboarded — generate fees regardless of whether the IPO calendar is active.
The stock price implications of this divergence are not subtle. Morgan Stanley’s 12-month share price gain was approximately 38.7%, driven by deal activity and the steady compounding of its wealth platform. Goldman’s Q1 EPS beat consensus by roughly 6.56%. Both are performing well. But they’re performing well for structurally different reasons, and that distinction matters when you’re thinking about which one holds up better if the M&A environment softens in Q3 or Q4.
What Q2 Actually Reveals
For Goldman, the Q2 question is whether the investment banking pipeline that drove Q1 has sustained momentum or whether deal closings were front-loaded into the quarter. Higher market volatility earlier this year increased trading volumes and financing fee revenues — that’s a real tailwind Goldman’s trading desks captured. If Q2 market conditions were less volatile (and the Dow’s record highs with tech selling suggests a mixed backdrop), Goldman’s FICC and equities trading lines could show sequential softening.
For Morgan Stanley, Q2 is simpler. Wealth Management doesn’t swing with market volatility the same way trading does. The recurring fee income from its $118 billion Q1 net new asset additions doesn’t disappear in a choppy quarter — it compounds. The Q2 report will likely show steadier, if slightly lower, revenue than Goldman, but with more earnings quality underneath.
Valuation and Institutional Positioning
Goldman Sachs moved up 3% on July 6 amid anticipation of its Q2 earnings, with analysts continuing to revise full-year EPS estimates upward. The bullish case rests on the resurgence of global deal-making — the debt ceiling resolution stabilized bond and equity markets, fueling advisory, underwriting, and equity listing demand in Q2. Goldman’s Q1 book value per share was $361.19, up 1% during the quarter.
Morgan Stanley’s wealth management mix gives it a structurally higher and more defensible P/E multiple compared to Goldman. The market is willing to pay up for recurring fee income in a way it historically hasn’t for trading revenue — and that premium is arguably not fully reflected in the current spread between the two stocks. One analyst at Motley Fool, previewing Q1, gave the slight long-term edge to Morgan Stanley citing more diversified revenue streams and a more durable earnings track record.
Three Scenarios for Next Week
Bull Case: Goldman beats Q2 EPS consensus and raises forward guidance, citing a robust M&A pipeline heading into Q3. M&A volumes globally have remained elevated, the capital markets business stays open, and trading revenue holds up better than the sequential step-down implies. Both stocks push higher. Goldman moves toward new 52-week highs.
Base Case: Goldman reports a clean but expected quarter — roughly $14 EPS and $15.88 billion in revenue. No major surprise either way. Morgan Stanley’s Q2 shows the wealth management flywheel is intact. Both stocks react modestly. The focus shifts to forward guidance on deal pipeline, credit quality, and whether net interest margins are holding.
Bear Case: Goldman’s trading revenue disappoints on a sequential basis. The M&A pipeline shows early signs of cooling as macro uncertainty around tariffs and the Fed meeting on July 28 creates client hesitation. Goldman stock corrects 5% to 8%. Morgan Stanley holds better due to the wealth management buffer.
Active Trader Strategy Framework
Goldman offers the higher beta play going into earnings — bigger upside if the investment banking beat is strong, bigger downside if it isn’t. The stock moved 3% on July 6 on analyst enthusiasm alone, suggesting the market is positioned constructively heading into July 14. Watch the investment banking revenue line specifically. Advisory, underwriting, and equity issuance tell you more about Q3 setup than any other metric.
Morgan Stanley is the lower-volatility expression of the same macro trade. If you believe the M&A cycle is real and the capital markets will stay open through Q3, Morgan Stanley gives you a cleaner earnings profile with a built-in wealth management cushion. The ROTCE of 27.1% in Q1 is a high bar — but one the firm has shown it can sustain. The Q2 number that matters most from Morgan Stanley isn’t EPS. It’s net new wealth assets. That tells you whether the compounding machine is still accelerating.
Between the two, Morgan Stanley is the more defensible holding across market conditions. Goldman is the better trade if Q2 investment banking surprises to the upside. The distinction matters — and July 14 will clarify which story the market is paying for.
For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.
